A JAMA Cardiology analysis found acoramidis slowed decline in daily function for ATTR-CM patients. Here is what the 30-month data show.
Acoramidis Slowed the Decline in Daily Function for Amyloid Heart Disease Patients, a New Trial Analysis Finds
by | Jul 31, 2026 | Uncategorized | 0 comments

Recent Comments